In the end, miR-206 directly targets glucose-6-phosphate dehydrogenase (G6PD) and downregulates the expression of G6PD to inhibit hepatocellular carcinoma cell growth (Fig. 5) [29]. This evidence concerns the gene G6PD and hepatocellular carcinoma.